AKANDA CORP AKAN

US Materials Medicinal Chemicals & Botanical Products
$12.33
-9.5%
52w: $2.68 – $107.43

Latest 13F among current holders filed 3 months ago (May 15, 2026)

Price — last 12 months

research preview data
2.6855.06107.43
Aug 18, 2025 Jul 2, 2026
Institutional holders
6
-1 QoQ
13F value
$31K
-24.3% QoQ
Smart-money holders
0
signal tier ≥ 2
New smart buyers
0
Q1 2026

Institutional value by quarter

$22K
Q1 2024
$11K
Q2 2024
$0
Q3 2024
$24K
Q4 2024
$16K
Q1 2025
$42K
Q2 2025
$288
Q3 2025
$41K
Q4 2025
$31K
Q1 2026

Number of holders

5
Q1 2024
3
Q2 2024
1
Q3 2024
3
Q4 2024
3
Q1 2025
5
Q2 2025
2
Q3 2025
7
Q4 2025
6
Q1 2026

Who owns AKAN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
CONTINUUM WEALTH ADVISORS, LLC Wealth advisor16.7K$12K0.0%New
HRT FINANCIAL LP Diversified mechanical15.6K$10K0.0%New
XTX Topco Ltd Market maker11.4K$8K0.0%New
UBS Group AG Bank broker2.3K$2K0.0%New
SBI Securities Co., Ltd. Diversified mechanical10$70.0%New
Vision Retirement, LLC Other8$60.0%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.